These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 33923668)
21. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases. Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479 [TBL] [Abstract][Full Text] [Related]
22. The maternal and child health sites' practices regarding HIV education, counseling, and testing of women of reproductive age in Chicago: barriers to universal implementation. Rahimian A; Driscoll M; Taylor D Matern Child Health J; 1998 Mar; 2(1):35-44. PubMed ID: 10728257 [TBL] [Abstract][Full Text] [Related]
23. Supporting patients with mental illness: Deconstructing barriers to community pharmacist access. Calogero S; Caley CF J Am Pharm Assoc (2003); 2017; 57(2):248-255. PubMed ID: 28153705 [TBL] [Abstract][Full Text] [Related]
24. Pharmacists and HIV/AIDS prevention: review of the literature. Deas C; McCree DH J Am Pharm Assoc (2003); 2010; 50(3):411-5. PubMed ID: 20452917 [TBL] [Abstract][Full Text] [Related]
25. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931 [TBL] [Abstract][Full Text] [Related]
26. Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting. Elaro A; Bosnic-Anticevich S; Kraus K; Farris KB; Shah S; Armour C; Patel MR Int J Clin Pharm; 2017 Aug; 39(4):935-944. PubMed ID: 28497209 [TBL] [Abstract][Full Text] [Related]
27. Tobacco treatment practices of pharmacists in Montana. Dent LA; Harris KJ; Noonan CW J Am Pharm Assoc (2003); 2010; 50(5):575-9. PubMed ID: 20833614 [TBL] [Abstract][Full Text] [Related]
28. A national survey exploring oral healthcare service provision across Australian community pharmacies. Freeman CR; Abdullah N; Ford PJ; Taing MW BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey. Wibowo Y; Parsons R; Sunderland B; Hughes J Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291 [TBL] [Abstract][Full Text] [Related]
30. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes. Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148 [TBL] [Abstract][Full Text] [Related]
31. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center. Isho NY; Kachlic MD; Marcelo JC; Martin MT J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379 [TBL] [Abstract][Full Text] [Related]
32. National survey of pharmacy-based immunization services. Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631 [TBL] [Abstract][Full Text] [Related]
33. Description of the characteristics of pharmacist-based immunization services in North Carolina: results of a pharmacist survey. Kummer GL; Foushee LL J Am Pharm Assoc (2003); 2008; 48(6):744-51. PubMed ID: 19019803 [TBL] [Abstract][Full Text] [Related]
34. Barriers to providing cognitive services. Raisch DW Am Pharm; 1993 Dec; NS33(12):54-8. PubMed ID: 8304273 [TBL] [Abstract][Full Text] [Related]
35. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: An exploratory study. Howard MS; DiDonato KL; Janovick DL; Schroeder MN; Powers MF; Azzi AG; Lengel AJ J Am Pharm Assoc (2003); 2018; 58(4S):S30-S36.e2. PubMed ID: 30006185 [TBL] [Abstract][Full Text] [Related]
36. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California. Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570 [TBL] [Abstract][Full Text] [Related]
37. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis. Shaeer KM; Sherman EM; Shafiq S; Hardigan P J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624 [TBL] [Abstract][Full Text] [Related]
38. Implementation of technician-driven medication therapy management program in community pharmacies. Burnside TPT; Scott NJ; Smith MG J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039 [TBL] [Abstract][Full Text] [Related]
39. Pharmacists' comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy. Lio I; Remines J; Nadpara PA; Goode JKR J Am Pharm Assoc (2003); 2018; 58(4S):S89-S93. PubMed ID: 30006191 [TBL] [Abstract][Full Text] [Related]
40. Pharmacists' attitudes regarding provision of sexual and reproductive health services. Hilverding AT; DiPietro Mager NA J Am Pharm Assoc (2003); 2017; 57(4):493-497. PubMed ID: 28619391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]